Adoptive transfer of T cells transduced with a chimeric antigen receptor to treat relapsed or refractory acute leukemia: efficacy and feasibility of immunotherapy approaches
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-1889
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Adoptive transfer of T cells transduced with a chimeric antigen receptor to treat relapsed or refractory acute leukemia: efficacy and feasibility of immunotherapy approaches ; day:3 ; month:5 ; year:2016 ; pages:1-5
Science China / Life sciences. Life sciences ; (3.5.2016), 1-5
- Creator
-
Ding, Guoliang
- Contributor
-
Chen, Hu
SpringerLink (Online service)
- DOI
-
10.1007/s11427-016-0017-3
- URN
-
urn:nbn:de:1111-20160505962
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ding, Guoliang
- Chen, Hu
- SpringerLink (Online service)
Other Objects (12)
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
Augmenting adoptive T cell therapy through universal chimeric costimulators
Infectious complications in pediatric patients undergoing CD19+CD22+ chimeric antigen receptor T-cell therapy for relapsed/refractory B-lymphoblastic leukemia
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of relapsed-refractory diffuse large B cell lymphoma
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
Augmenting adoptive T cell therapy through universal chimeric costimulators
Infectious complications in pediatric patients undergoing CD19+CD22+ chimeric antigen receptor T-cell therapy for relapsed/refractory B-lymphoblastic leukemia
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Management of relapsed-refractory diffuse large B cell lymphoma
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
Augmenting adoptive T cell therapy through universal chimeric costimulators
Infectious complications in pediatric patients undergoing CD19+CD22+ chimeric antigen receptor T-cell therapy for relapsed/refractory B-lymphoblastic leukemia
Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Improvement of Chimeric Antigen Receptor-Specific T Cells for Adoptive T Cell Transfer
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
Management of Relapsed and Refractory Multiple Myeloma: Recent advances
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma